Neuroendocrine Tumor Treatment
AssigneeNovartis AG
InventorsPeter Wayne Marks, David Lebwohl
Life of this patent
Estimating the term…
Abstract
A method for treating endocrine tumors by administration of an mTOR inhibitor, optionally in combination with another drug.
Claims12
A method for treating endocrine tumors, comprising administering to a subject in need thereof a therapeutically effective amount of an mTOR inhibitor.
A method for inhibiting growth of endocrine tumors, comprising administering to a subject in need thereof a therapeutical effective amount of an mTOR inhibitor.
A method for inhibiting or controlling endocrine tumors, comprising administering to a subject in need thereof a therapeutically effective amount of an mTOR inhibitor.
A method for inducing endocrine tumor regression, comprising administering to a subject in need thereof a therapeutically effective amount of an mTOR inhibitor.
A method for treating endocrine tumor invasiveness or symptoms associated with such tumor growth, comprising administering to a subject in need thereof a therapeutically effective amount of an mTOR inhibitor.
A method for preventing metastatic spread of endocrine tumors or for preventing or inhibiting growth of micrometastasis, comprising administering to a subject in need thereof a therapeutically effective amount of an mTOR inhibitor.
A method for the treatment of a disorder associated with endocrine tumors, comprising administering to a subject in need thereof a therapeutically effective amount of an mTOR inhibitor.
Dependencies are inferred from the claim text.